Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

ClinicalTrials.gov ID: NCT00066469

Public ClinicalTrials.gov record NCT00066469. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Cyclophosphamide, Prednisone and Rituximab (CPR) in Children, Adolescents and Young Adults With B-lymphocyte Antigen CD20 (CD20) Positive Post-Transplant Lymphoproliferative Disease (PTLD) Following Solid Organ Transplantation (SOT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy such as cyclophosphamide, prednisone, and methylprednisolone use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Combining cyclophosphamide and either prednisone or methylprednisolone with rituximab may be effective in treating lymphoproliferative disease following organ transplantation. PURPOSE: Phase II trial to study the effectiveness of combining cyclophosphamide and either prednisone or methylprednisolone with rituximab in treating patients who have Epstein-Barr virus-positive lymphoproliferative disease following organ transplantation.

Study identification

NCT ID
NCT00066469
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Children's Oncology Group
Network
Enrollment
55 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
Up to 30 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2004 (Type not available)
Primary completion
Oct 1, 2009 (Actual)
Completion
Dec 31, 2013 (Actual)
Last update posted
Aug 6, 2019

2004 – 2013

United States locations

U.S. sites
66
U.S. states
33
U.S. cities
61
Facility City State ZIP Site status
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham Alabama 35294 —
Phoenix Children's Hospital Phoenix Arizona 85016-7710 —
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Southern California Permanente Medical Group Downey California 90242-2814 —
Loma Linda University Cancer Institute at Loma Linda University Medical Center Loma Linda California 92354 —
Kaiser Permanente Medical Center - Oakland Sacramento California 95825 —
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 —
Stanford Cancer Center Stanford California 94305-5824 —
Children's Hospital Center for Cancer and Blood Disorders Aurora Colorado 80045 —
Alfred I. duPont Hospital for Children Wilmington Delaware 19803 —
Lee Cancer Care of Lee Memorial Health System Fort Myers Florida 33901 —
University of Florida Shands Cancer Center Gainesville Florida 32610-0232 —
Nemours Children's Clinic Jacksonville Florida 32207 —
University of Miami Sylvester Comprehensive Cancer Center - Miami Miami Florida 33136 —
Sacred Heart Cancer Center at Sacred Heart Hospital Pensacola Florida 32504 —
All Children's Hospital St. Petersburg Florida 33701 —
Winship Cancer Institute of Emory University Atlanta Georgia 30322 —
University of Illinois Cancer Center Chicago Illinois 60612-7243 —
Children's Memorial Hospital - Chicago Chicago Illinois 60614 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Simmons Cooper Cancer Institute Springfield Illinois 62794-9677 —
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202-5289 —
Kosair Children's Hospital Louisville Kentucky 40232 —
Tulane Cancer Center Office of Clinical Research Alexandria Louisiana 71315-3198 —
C.S. Mott Children's Hospital at University of Michigan Medical Center Ann Arbor Michigan 48109-0286 —
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201-1379 —
Butterworth Hospital at Spectrum Health Grand Rapids Michigan 49503-2560 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-5341 —
Masonic Cancer Center at University of Minnesota Minneapolis Minnesota 55455 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
University of Mississippi Cancer Clinic Jackson Mississippi 39216-4505 —
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203 —
Children's Mercy Hospital Kansas City Missouri 64108 —
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110 —
UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha Nebraska 68198-6805 —
Sunrise Hospital and Medical Center Las Vegas Nevada 89109-2306 —
Hackensack University Medical Center Cancer Center Hackensack New Jersey 07601 —
Mount Sinai Medical Center New York New York 10029 —
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York New York 10032 —
James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York 14642 —
SUNY Upstate Medical University Hospital Syracuse New York 13210 —
New York Medical College Valhalla New York 10595 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295 —
Blumenthal Cancer Center at Carolinas Medical Center Charlotte North Carolina 28232-2861 —
Akron Children's Hospital Akron Ohio 44308-1062 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229-3039 —
Rainbow Babies and Children's Hospital Cleveland Ohio 44106-5000 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Nationwide Children's Hospital Columbus Ohio 43205-2696 —
Oklahoma University Cancer Institute Oklahoma City Oklahoma 73104 —
Legacy Emanuel Hospital and Health Center and Children's Hospital Portland Oregon 97227 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104-9786 —
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213 —
East Tennessee Children's Hospital Knoxville Tennessee 37901 —
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838 —
Driscoll Children's Hospital Corpus Christi Texas 78411 —
Medical City Dallas Hospital Dallas Texas 75230 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78207 —
Methodist Children's Hospital of South Texas San Antonio Texas 78229-3993 —
Primary Children's Medical Center Salt Lake City Utah 84113-1100 —
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401 —
Inova Fairfax Hospital Falls Church Virginia 22042-3300 —
Children's Hospital of The King's Daughters Norfolk Virginia 23507-1971 —
Children's Hospital and Regional Medical Center - Seattle Seattle Washington 98105 —
West Virginia University Health Sciences Center - Charleston Charleston West Virginia 25302 —
Marshfield Clinic - Marshfield Center Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00066469, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00066469 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →